md-medicaldata

Authors

 

Milica Mastilović¹, Aljoša Mandić^{1, 2}, Nataša Prvulović Bunović<sup>1, 3

1</sup>Medical Faculty University of Novi Sad
²Clinic for oncological surgery, Oncology Institute of Vojvodina
³Center for Imaging Diagnostic, Oncology Institute of Vojvodina

 

UDK: 618.146-006-074"2018"

The paper was received / Rad primljen: 12.10.2020.

Accepted / Rad prihvaćen: 25.10.2020.

 

Correspondence to:

Milica Mastilović,
Medical faculty University of Novi Sad, Serbia.
e-mail: milica.mastilovic@hotmail.com

 

 

Abstract

Cancer of the cervix uteri represents major socioeconomic problem, given the incidence which, regardless of prevention measures, remains at high level, particularly in countries of lower socioeconomic status. Cervical cancer is the fourth most common cause of cancer incidence in women. Accurate assessment of disease stage is a prerequisite for a selection of adequate therapeutic modality.Used for many years, the International Federation of Gynecology and Obstetrics (FIGO) classification did not meet criteria of the spread of the disease and thus it became insufficient. Compared to the previous classification, which was based on clinical evaluation of the stage of disease based on gynecological examination and other diagnostic methods, revised FIGO classification includes radiologic imaging modalities and pathological assessment, as a supplement to clinical evaluation, in determination of the stage of cervical cancer for all stages of cervical cancer.Diagnostics and treatment of patients with cervical cancer is based on multidisciplinary approach.

Key words:

cervical cancer; FIGO classification; imaging

 

 

Sažetak

Karcinom grlića materice i dalje predstavlja veliki socioekonomski problem, obzirom na incidencu cervikalnog carcinoma koja se i pored mera prevencije i dalje održava na visokom nivou, naročito u zemljama nižeg socioekonomskog razvoja. Karcinom grlića materice četvrti je karcinom po učestalosti kod žena. Precizna procena stadijuma bolesti preduslov je za izbor adekvatnog terapijskog modaliteta.Dugo godina upotrebljavana FIGO klasifikacija nije zadovoljavala kriterijume proširenosti bolesti i samim tim postala je insuficijentna. U odnosu na prethodnu FIGO klasifikaciju, koja je bila bazirana na kliničkom procenjivanju stadijuma bolesti na osnovu ginekološkog pregleda i pomoću drugih dijagnostičkih metoda, revidirana FIGO klasifikacija uključuje radiološke imidžing metode i patološku procenu u određivanju stadijuma karcinoma grlića materice i to za sve stadijume bolesti, kao dopuna kliničkoj proceni kada su radiološke metode dostupne. Dijagnostika i lečenje pacijentkinja obolelih od karcinoma grlića materice zasniva se na multidisciplinarnom pristupu.

Ključne reči:

cervicalni karcinom; FIGO klasifikacija; imidžing

 

 

References:

1. Cervical cancer [Internet]. Who.int. 2020 [cited 26 June 2020]. Available from: https://www.who.int/health-topics/cervical-cancer#tab=tab_1
2. European cervical cancer prevention week (21st – 27thJanuary 2019) [Internet]. IZJZV, Institute of Public Health of Vojvodina. 2020 [cited 26 June 2020]. Available from: http://www.izjzv.org.rs/?lng=lat&cir=0&link=3-18-1140(Serbian)
3. Burd E. Human Papillomavirus and Cervical Cancer. Clinical Microbiology Reviews. 2003;16(1):1-17.
4. Haldorsen I, Lura N, Blaakær J, Fischerova D, Werner H. What Is the Role of Imaging at Primary Diagnostic Work-Up in Uterine Cervical Cancer?. Current Oncology Reports. 2019;21(9).
5. Lee S, Atri M. 2018 FIGO Staging System for Uterine Cervical Cancer: Enter Cross-sectional Imaging. Radiology. 2019;292(1):15-24.
6. Berek J, Matsuo K, Grubbs B, Gaffney D, Lee S, Kilcoyne A et al. Multidisciplinary perspectives on newly revised 2018 FIGO staging of cancer of the cervix uteri. Journal of Gynecologic Oncology. 2019;30(2).
7. Bhatla N, Berek J, CuelloFredes M, Denny L, Grenman S, Karunaratne K et al. Revised FIGO staging for carcinoma of the cervix uteri. International Journal of Gynecology & Obstetrics. 2019;145(1):129-135.
8. Jolly S, Uppal S, Bhatla N, Johnston C, Maturen K. Improving Global Outcomes in Cervical Cancer: The Time Has Come for International Federation of Gynecology and Obstetrics Staging to Formally Incorporate Advanced Imaging. Journal of Global Oncology. 2018;(4):1-6.
9. Hameeduddin A, Sahdev A. Diffusion-weighted imaging and dynamic contrast-enhanced MRI in assessing response and recurrent disease in gynaecological malignancies. Cancer Imaging. 2015;15(1).
10. Matsuo K, Machida H, Mandelbaum R, Konishi I, Mikami M. Validation of the 2018 FIGO cervical cancer staging system. Gynecologic Oncology. 2019;152(1):87-93.
11. Plante M, Renaud M, Sebastianelli A, Gregoire J. Simple Vaginal Trachelectomy. International Journal of Gynecological Cancer. 2017;27(5):1021-1027.
12. De Gregorio A, Widschwendter P, Ebner F, Friedl T, Huober J, Janni W et al. Influence of the New FIGO Classification for Cervical Cancer on Patient Survival: A Retrospective Analysis of 265 Histologically Confirmed Cases with FIGO Stages IA to IIB. Oncology. 2019;98(2):91-97.
    

PDF 05-Vol 12 No4 Mastilović